MICHAEL KAUZLARICH: Open Payments
NPI 1477539542 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 33 payments from 12 companies in 2025. Trend: 2023 $686 · 2024 $569 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $164 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| INOGEN, INC. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Ozempic, XIFAXAN, FARXIGA, MOUNJARO, AIRSUPRA, EVENITY, VOQUEZNA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.
Industry payments across TN — which companies pay providers there.
